Jupiter Neurosciences Inc (JUNS)

$0.64 +0.01 (2.16%)
Market Cap 20.71M
Revenue (ttm) 0.00
Net Income (ttm) -4.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 90,200
Avg Vol 680,674
Day's Range N/A - N/A
Shares Out 33.10M
Stochastic %K 30%
Beta N/A
Analysts Strong Sell
Price Target $30.00

Latest News on JUNS

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Feb 4, 2025, 9:25 AM EST - 2 months ago

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jan 30, 2025, 8:00 AM EST - 2 months ago

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Dec 4, 2024, 4:56 PM EST - 4 months ago

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Dec 2, 2024, 7:00 PM EST - 4 months ago

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO

Aug 16, 2022, 5:48 PM EDT - 2 years ago

Neuro-inflammation biotech Jupiter Neurosciences revises terms, removes warrants ahead of $15 million IPO